EP3638243
Aðferðir til meðhöndlunar á mergvaxtar-æxlis-tengdri beinmergstrefjun og blóðleysi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.6.2018EP published:
7.8.2024EP application number:
18816685.4
EP translation filed:
21.10.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
12.6.2038Expiry date:
12.6.2026Next due date:
30.6.2026
Title in English:
METHODS FOR TREATING MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED MYELOFIBROSIS AND ANEMIALanguage of the patent:
English
Timeline
Today
13.6.2018EP application
7.8.2024EP Publication
21.10.2024Translation submitted
15.11.2024Registration published
12.6.2026Expires
Owner
Name:
Celgene CorporationAddress:
Route 206 & Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
LAADEM, AbderrahmaneAddress:
Belle Mead NJ 08502, US
Name:
GALE, RobertAddress:
Los Angeles CA 90077, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201762519725 PDate:
14.6.2017Country:
US
Number:
201862679210 PDate:
1.6.2018Country:
US
Classification
Categories:
A61K 31/519, A61K 45/06, C07K 14/495, A61K 38/17, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 2.6.2025
Expires: 12.6.2026
Payer: Árnason Faktor ehf.